OPTIBUMIN Trademark

Trademark Overview


On Tuesday, August 28, 2018, a trademark application was filed for OPTIBUMIN with the United States Patent and Trademark Office. The USPTO has given the OPTIBUMIN trademark a serial number of 88095267. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, December 20, 2024. This trademark is owned by Ventria Bioscience Inc.. The OPTIBUMIN trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Recombinant albumin for biological therapeutic purposes; Recombinant albumin for use as a reagent for medical use, namely, in-vitro fertilization, tissue sealant, tissue and cell cryopreservation, and blood detoxification

Recombinant albumin in the nature of excipients for use in the manufacture of pharmaceutical preparations, cellular therapies, gene therapies and vaccines; Recombinant albumin for use as a reagent for scientific and research use, namely, biomedical research and development
optibumin

General Information


Serial Number88095267
Word MarkOPTIBUMIN
Filing DateTuesday, August 28, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, December 20, 2024
Registration Number5749521
Registration DateTuesday, May 14, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 26, 2019

Trademark Statements


Description of MarkThe mark consists of the word "OPTIBUMIN" under a tapering arc whose wider end begins at the top right of the letter "O".
Goods and ServicesRecombinant albumin for biological therapeutic purposes; Recombinant albumin for use as a reagent for medical use, namely, in-vitro fertilization, tissue sealant, tissue and cell cryopreservation, and blood detoxification
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesRecombinant albumin in the nature of excipients for use in the manufacture of pharmaceutical preparations, cellular therapies, gene therapies and vaccines; Recombinant albumin for use as a reagent for scientific and research use, namely, biomedical research and development

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, November 2, 2018
Primary Code001
First Use Anywhere DateFriday, July 31, 2015
First Use In Commerce DateFriday, July 31, 2015

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 6, 2018
Primary Code005
First Use Anywhere DateFriday, July 31, 2015
First Use In Commerce DateFriday, July 31, 2015

Trademark Owner History


Party NameINVITRIA, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressJUNCTION CITY, KS 66441

Party NameVentria Bioscience Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJunction City, KS 66441

Party NameVentria Bioscience Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJunction City, KS 66441

Party NameVentria Bioscience Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJunction City, KS 66441

Trademark Events


Event DateEvent Description
Friday, August 31, 2018NEW APPLICATION ENTERED
Thursday, September 6, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 7, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, November 1, 2018ASSIGNED TO EXAMINER
Friday, November 2, 2018EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Friday, November 2, 2018COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Friday, November 2, 2018EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, November 2, 2018NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, January 2, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 2, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 3, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 4, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, January 20, 2019ASSIGNED TO LIE
Wednesday, February 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 26, 2019PUBLISHED FOR OPPOSITION
Tuesday, February 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, September 13, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 14, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, July 22, 2024TEAS SECTION 8 & 15 RECEIVED
Friday, December 20, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, December 20, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, December 20, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED